Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Graphite Market Forecast: Top Trends for Graphite in 2026 January 20, 2026 FORTUNE BAY MOVES INTO 2026 FOCUSED ON EXPEDITED ADVANCEMENT OF GOLDFIELDS January 20, 2026 LAURION Provides Strategic Update for 2026: Advancing Ishkoday through Disciplined Execution January 20, 2026
LAURION Provides Strategic Update for 2026: Advancing Ishkoday through Disciplined Execution January 20, 2026